Patterns of epidermal growth factor receptor amplification in malignant gliomas (original) (raw)

. 1996 Apr;148(4):1047–1053.

Abstract

Amplification of the gene for epidermal growth factor receptor (EGFR) is a common finding in malignant gliomas. We found that 18 of 29 grade 3 and grade 4 gliomas had EGFR amplification when assayed using fluorescence in situ hybridization. The amplification pattern suggests that the amplicon is contained within double minute chromosomes in most cases. EGFR copy number can differ by 20-fold in amplified cells within a single case. Polysomy 7 occurs frequently in both EGFR-amplified and -unamplified cells. More than one-third of the cases had < or = 10 percent of cells with amplified EGFR, and it is likely that these cases would not have been identified by methods that do not examine DNA on a cell by cell basis.

1047

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bello M. J., Moreno S., Rey J. A. Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma. Cancer Genet Cytogenet. 1989 Mar;38(1):133–135. doi: 10.1016/0165-4608(89)90175-1. [DOI] [PubMed] [Google Scholar]
  2. Betta P. G., Robutti F., Spinoglio G., Bottero G. Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness. Pathologica. 1989 Jul-Aug;81(1074):425–431. [PubMed] [Google Scholar]
  3. Bigner S. H., Mark J., Bigner D. D. Cytogenetics of human brain tumors. Cancer Genet Cytogenet. 1990 Jul 15;47(2):141–154. doi: 10.1016/0165-4608(90)90024-5. [DOI] [PubMed] [Google Scholar]
  4. Bilous M., Milliken J., Mathijs J. M. Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer. Eur J Cancer. 1992;28A(6-7):1033–1037. doi: 10.1016/0959-8049(92)90449-c. [DOI] [PubMed] [Google Scholar]
  5. Cavenee W. K., Scrable H. J., James C. D. Molecular genetics of human cancer predisposition and progression. Mutat Res. 1991 Apr;247(2):199–202. doi: 10.1016/0027-5107(91)90015-g. [DOI] [PubMed] [Google Scholar]
  6. Chaffanet M., Chauvin C., Lainé M., Berger F., Chédin M., Rost N., Nissou M. F., Benabid A. L. EGF receptor amplification and expression in human brain tumours. Eur J Cancer. 1992;28(1):11–17. doi: 10.1016/0959-8049(92)90374-b. [DOI] [PubMed] [Google Scholar]
  7. Colombatti M., Dipasquale B., Del-l'Arciprete L., Gerosa M., Tridente G. Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines. J Neurosurg. 1989 Sep;71(3):388–397. doi: 10.3171/jns.1989.71.3.0388. [DOI] [PubMed] [Google Scholar]
  8. Ekstrand A. J., Longo N., Hamid M. L., Olson J. J., Liu L., Collins V. P., James C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene. 1994 Aug;9(8):2313–2320. [PubMed] [Google Scholar]
  9. Frankel R. H., Bayona W., Koslow M., Newcomb E. W. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res. 1992 Mar 15;52(6):1427–1433. [PubMed] [Google Scholar]
  10. Fults D., Brockmeyer D., Tullous M. W., Pedone C. A., Cawthon R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 1992 Feb 1;52(3):674–679. [PubMed] [Google Scholar]
  11. Fults D., Pedone C. A., Thomas G. A., White R. Allelotype of human malignant astrocytoma. Cancer Res. 1990 Sep 15;50(18):5784–5789. [PubMed] [Google Scholar]
  12. Gasparini G., Bevilacqua P., Dal Fior S., Panizzoni G. A., Favretto S., Visonà A., Meli S. Characterization of node-negative breast cancer by clinico-pathologic and biologic factors. Anticancer Res. 1990 Jan-Feb;10(1):205–208. [PubMed] [Google Scholar]
  13. Gasparini G., Pozza F., Meli S., Reitano M., Santini G., Bevilacqua P. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res. 1991 Nov-Dec;11(6):2015–2021. [PubMed] [Google Scholar]
  14. Humphrey P. A., Wong A. J., Vogelstein B., Friedman H. S., Werner M. H., Bigner D. D., Bigner S. H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res. 1988 Apr 15;48(8):2231–2238. [PubMed] [Google Scholar]
  15. Hurtt M. R., Moossy J., Donovan-Peluso M., Locker J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol. 1992 Jan;51(1):84–90. doi: 10.1097/00005072-199201000-00010. [DOI] [PubMed] [Google Scholar]
  16. James C. D., Carlbom E., Dumanski J. P., Hansen M., Nordenskjold M., Collins V. P., Cavenee W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 1988 Oct 1;48(19):5546–5551. [PubMed] [Google Scholar]
  17. Kearsley J. H., Furlong K. L., Cooke R. A., Waters M. J. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer. 1990 Jun;61(6):821–827. doi: 10.1038/bjc.1990.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kinzler K. W., Bigner S. H., Bigner D. D., Trent J. M., Law M. L., O'Brien S. J., Wong A. J., Vogelstein B. Identification of an amplified, highly expressed gene in a human glioma. Science. 1987 Apr 3;236(4797):70–73. doi: 10.1126/science.3563490. [DOI] [PubMed] [Google Scholar]
  19. Limas C., Bair R., Bernhart P., Reddy P. Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. J Clin Pathol. 1993 Sep;46(9):810–816. doi: 10.1136/jcp.46.9.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mohapatra G., Kim D. H., Feuerstein B. G. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer. 1995 Jun;13(2):86–93. doi: 10.1002/gcc.2870130203. [DOI] [PubMed] [Google Scholar]
  21. Olopade O. I., Jenkins R. B., Ransom D. T., Malik K., Pomykala H., Nobori T., Cowan J. M., Rowley J. D., Diaz M. O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 1992 May 1;52(9):2523–2529. [PubMed] [Google Scholar]
  22. Prados M. D., Gutin P. H., Phillips T. L., Wara W. M., Larson D. A., Sneed P. K., Davis R. L., Ahn D. K., Lamborn K., Wilson C. B. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys. 1992;23(1):3–8. doi: 10.1016/0360-3016(92)90537-r. [DOI] [PubMed] [Google Scholar]
  23. Reifenberger G., Prior R., Deckert M., Wechsler W. Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):147–155. doi: 10.1007/BF00718594. [DOI] [PubMed] [Google Scholar]
  24. Sauter G., Haley J., Chew K., Kerschmann R., Moore D., Carroll P., Moch H., Gudat F., Mihatsch M. J., Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer. 1994 May 15;57(4):508–514. doi: 10.1002/ijc.2910570412. [DOI] [PubMed] [Google Scholar]
  25. Schlegel J., Merdes A., Stumm G., Albert F. K., Forsting M., Hynes N., Kiessling M. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer. 1994 Jan 2;56(1):72–77. doi: 10.1002/ijc.2910560114. [DOI] [PubMed] [Google Scholar]
  26. Strommer K., Hamou M. F., Diggelmann H., de Tribolet N. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) 1990;107(3-4):82–87. doi: 10.1007/BF01405784. [DOI] [PubMed] [Google Scholar]
  27. Toi M., Nakamura T., Mukaida H., Wada T., Osaki A., Yamada H., Toge T., Niimoto M., Hattori T. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer. 1990 May 1;65(9):1980–1984. doi: 10.1002/1097-0142(19900501)65:9<1980::aid-cncr2820650917>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  28. Torp S. H., Helseth E., Dalen A., Unsgaard G. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir (Wien) 1992;117(3-4):182–186. doi: 10.1007/BF01400618. [DOI] [PubMed] [Google Scholar]
  29. Torp S. H., Helseth E., Ryan L., Stølan S., Dalen A., Unsgaard G. Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res. 1991 Nov-Dec;11(6):2095–2098. [PubMed] [Google Scholar]
  30. Von Hoff D. D., McGill J. R., Forseth B. J., Davidson K. K., Bradley T. P., Van Devanter D. R., Wahl G. M. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8165–8169. doi: 10.1073/pnas.89.17.8165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Walker R. A., Camplejohn R. S. DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol. 1986 Sep;150(1):37–42. doi: 10.1002/path.1711500107. [DOI] [PubMed] [Google Scholar]
  32. Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899–6903. doi: 10.1073/pnas.84.19.6899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wrba F., Reiner A., Ritzinger E., Holzner J. H., Reiner G. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study. Pathol Res Pract. 1988 Feb;183(1):25–29. [PubMed] [Google Scholar]